Financial intelligence for Asia's healthcare markets
 
 
Remember me:

China: Fresenius opens dialysis centre in Quanzhou

German healthcare giant Fresenius has opened its first independent dialysis centre in Quanzhou, China.

“The opening of our first independent and stand-alone Fresenius Medical Care dialysis centre in Quanzhou is another important milestone for us on the way to further expand our business in China”, said Harry de Wit, CEO of Fresenius Medical Care Asia Pacific. “By working closely with the Fujian government, we built the centre in order to perfectly meet the needs of kidney patients in the region”.

Located in the Licheng District of Quanzhou, the centre offers treatment at 50 dialysis stations. Multiple dialysis modalities from high-flux haemodialysis to haemodiafiltration are provided. The centre, launched as Fresenius Kidney Care Quanzhou Dialysis Centre, aims to provide high quality and safe dialysis as well as other related medical services for patients with chronic kidney disease.

Posted on: 05/12/2017 UTC+08:00


News

Chularat Hospital, which operates 13 clinics and hospitals in Thailand, intends to build the Suvarnabhumi Cancer and Radiologist Center Hospital, which will provide specialised medical services to general patients and counterparties in Samutprakan and nearby provinces.
Thomson Medical Group (TMG), Singapore’s second largest healthcare group, has reported EBITDA of S$23.4 million (US$17.1 million) on the back of total revenue for the first half of the year at S$105.5 million.
Healthcare services group Clearbridge Health has reported revenue of S$1.46 million (US$1.1 million) for the three months ended 30 June 2018. The topline growth is nearly four times the S$0.38 million achieved by the group in Q1 and mainly attributed to recent acquisitions including a medical centre in the Philippines in January and in Singapore and Indonesia in April.
Australian hearing implant manufacturer Cochlear delivered net profit of A$245.8 million, an increase of 10% on FY17, which was within the guidance range of A$240-250 million. Chief executive and president Dig Howitt said, “Cochlear continues to deliver on its objective of delivering consistent revenue and earnings growth over time.
Shareholders of Fortis Healthcare, the country’s second largest private hospital chain, have approved the US$584.1 million acquisition plan by IHH Healthcare, Asia’s largest healthcare company – 99.7% voted in favour of the deal.
Retirement village operator Summerset Group Holdings has announced an underlying profit of NZ$45.2 million (US$29.7 million), an increase of 27%, in line with the profit guidance provided in early July.
Leading fully integrated plasma-based biopharmaceutical company China Biologic Products Holdings has appointed Bing Li as chief executive officer. By assuming the CEO position, Li has moved from an independent director to an executive director of the board. Zhijun Tong, the former acting CEO, will continue to serve as an executive director of the board and president of the company.
Beijing-based paediatric healthcare provider New Century Healthcare has taken a 10.1% stake in Chiron Healthcare. Financial terms have not been disclosed.



Analysis

First you must find a clinic space from which to practice. The good news is that space is available at most hospitals. The bad news is that a 1,200 square-foot clinic space at Mount Elizabeth Hospital currently retails for around S$10 million, or US$7.34 million to secure a space less than half the size of a tennis court. By the time you add fittings, equipment and staff, your relationship with your bank manager will likely be under severe strain.
China’s hospital landscape is rapidly changing as operators and owners respond to shifting policy incentives, an aging population, the opportunity to serve Tier 2 and 3 cities, and shifts in consumer preferences.
Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.
CR Phoenix Healthcare, China’s largest private hospital group, recently announced plans to restructure Beijing Jingmei Group General Hospital, a flagship hospital managed by CR Phoenix under its investment-operation-transfer (IOT) model.
Severe abuses continue in China's organ transplant system – including the sourcing of organs from prisoners of conscience on a large scale – despite Chinese government assertions of reform, finds a new study by the China Organ Harvest Research Center.
Asia Pacific's transition from a volume- to value-based care model has been highly challenging due to the need for large-scale regulatory changes and lack of a funding. Rising healthcare consumerism, digital health adoption, and the growing influence of medical tourism are setting a foundation for population health management, one form of value-based care that shifts the industry focus from episodic, individualised healthcare approaches to collective action against the cost and burden of disease in a society.
Leaders from New Zealand’s health technology industry are looking to Malaysia as a strategic investment opportunity to support the country’s rapidly growing healthcare market.
Ping An Healthcare and Technology, formerly known as Good Doctor, has signed contracts with nearly 200 large corporations, including Vanke, Greentown, Bank of China, China Telecom, China National Nuclear Power, Evergrande Group and provides services to nearly 1.5 million employees, covering 27 provinces, autonomous regions and municipalities.
my images

Podcasts

HealthInvestor Asia twitter feed